1,757
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Short Report

Pediatric hematology/oncology physician and nurse practitioner attitudes towards the COVID-19 vaccines: A qualitative study

ORCID Icon, , , , , & ORCID Icon show all
Article: 2048560 | Received 26 Dec 2021, Accepted 25 Feb 2022, Published online: 28 Mar 2022

References

  • World Health Organization. WHO Coronavirus (COVID-19) dashboard. [ updated 2021 May 28; accessed 2021 May 28]. https://covid19.who.int/ .
  • American Academy of Pediatrics. Clinical updates on COVID-19. [ updated 2021 Nov; accessed 2021 Nov 15]. https://www.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/ .
  • Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–6. doi:10.1542/peds.2013-2037.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764. doi:10.1542/peds.2016-1764.
  • Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human Papillomavirus vaccination: an analysis of audio recordings. J Adolesc Health. 2017;61(2):246–51. doi:10.1016/j.jadohealth.2017.02.006.
  • Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci U S A. 2021;c118(10):e2021726118. doi:10.1073/pnas.2021726118.
  • Ahmed G, Almoosa Z, Mohamed D, Rapal J, Minguez O, Abu Khurma I, Alnems A, Al Mutair A. Healthcare provider attitudes toward the newly developed COVID-19 vaccine cross-sectional study. Nurs Rep. 2021;11:187–94. doi:10.3390/nursrep11010018.
  • Ledda C, Costantino C, Cuccia M, Maltezou HC, Rapisarda V. Attitudes of healthcare personnel towards vaccinations before and during the COVID-19 pandemic. Int J Environ Res Public Health. 2021;18(5):2703. doi:10.3390/ijerph18052703.
  • Grady MP. Qualitative and action research: a practitioner handbook. Bloomington: Phi Delta Kappa Educational Foundation; 1998.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101. doi:10.1191/1478088706qp063oa.
  • Head KJ, Kasting ML, Sturm LA, Hartsock JA, Zimet GD. A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts. Sci Commun. 2020;42(5):698–723. doi:10.1177/1075547020960463.
  • Kreps S, Prasad S, Brownstein JS, Hswen Y, Garibaldi BT, Zhang B, Kriner DL. Factors associated with US adults’ likelihood of accepting COVID-19 vaccination. JAMA Netw Open. 2020;3(10):e2025594. doi:10.1001/jamanetworkopen.2020.25594.
  • Goldman RD, Yan TD, Seiler M, Parra Cotanda C, Brown JC, Klein EJ, Hoeffe J, Gelernter R, Hall JE, Davis AL; International COVID-19 Parental Attitude Study (COVIPAS) Group. Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey. Vaccine. 2020;38(48):7668–73. doi:10.1016/j.vaccine.2020.09.084.
  • Yasmin F, Najeeb H, Moeed A, Naeem U, Asghar MS, Chughtai NU, Yousaf Z, Seboka BT, Ullah I, Lin CY. COVID-19 vaccine hesitancy in the United States: a systematic review. Front Public Health. 2021;9:770985. doi:10.3389/fpubh.2021.770985.
  • Hetherington E, Edwards SA, MacDonald SE, Racine N, Madigan S, McDonald S, Tough S. SARS-CoV-2 vaccination intentions among mothers of children aged 9 to 12 years: a survey of the All Our Families cohort. CMAJ Open. 2021;9(2):E548–E555. doi:10.9778/cmajo.20200302.
  • Frenck RW, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S Bailey, R, et al. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. NEJM. 2021. doi:10.1056/NEJMoa2107456.
  • U.S Food and Drug Administration. FDA authorizes Pfizer-BioNtech COVID-19 vaccine for emergency use in children 5 through 11 years of age. [ updated 2021 Oct; accessed 2021, Nov 07]. https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age.